Novo Nordisk's Wegovy launches in China, offering obesity drug at a fraction of US prices [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Now, people in China will have access to Wegovy, potentially at a much lower price than in the United States. According to Reuters and CNN , Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, the world's second-largest pharmaceuticals market, where more than 180 million people live with obesity. Eli Lilly, Novo Nordisk's direct competitor and the manufacturer of Mounjaro and Zepbound, has also secured approval for its obesity treatments in the country, but has yet to launch them. Both companies are ramping up production to capitalize on the growing weight-loss market, which analysts project could exceed $150 billion by the start of the next decade, CNN reported. A dose of four Wegovy injections will cost 1,400 yuan ($194), a fraction of the drug's U.S. price, according to the Chinese website Yicai . However, patients in China will have to pay out of pocket for the treatment, as it is not yet covered by the national healthcare insurance,
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop [Yahoo! Finance]Yahoo! Finance
- Useless Europe is sleepwalking into oblivion [Yahoo! Finance]Yahoo! Finance
- Weight loss drug makers still have huge upside, and the market overreacted to RFK Jr. named to top health role, BMO says [Yahoo! Finance]Yahoo! Finance
- Weight loss drug makers still have huge upside, and the market overreacted to RFK Jr. named to top health role, BMO says [Business Insider]Business Insider
- Is Novo Nordisk Stock a Buy Right Now? [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/7/24 - Beat
NVO
Sec Filings
- 11/19/24 - Form 6-K
- 11/18/24 - Form 6-K
- 11/14/24 - Form 6-K
- NVO's page on the SEC website